Back

Five-year outcomes with self-expanding versus balloon-expandable transcatheter aortic valve replacement in patients with left ventricular systolic dysfunction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: TAVI and beyond Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masaaki Nakase

University of Bern, Bern (Switzerland)

8 More presentations in this session

Presentation thumbnail
Prospective evaluation of transcatheter aortic valve implantation (TAVI) with coronary alignment and impact on coronary access
Doctor C. pavitt (Brighton, GB)
Abstract Slides Video
Presentation thumbnail
Implementing a novel selection criteria and pathway for same-day discharge after TAVI
Doctor R. Sethi (Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function
Doctor K. Hu (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Correlation of prosthesis position on mid-term pacing burden in patients with new permanent pacemaker after TAVI
Doctor P. Breitbart (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of mortality scores performance in transcatheter aortic valve replacement: suiting up to percutaneous intervention.
Doctor A. Martins (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI and beyond

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Ballon vs self-expandable valves : pacemaker implantation analysis
thumbnail
Congress Presentation
Association between transcatheter heart valve type and periprocedural myocardial injury in transcatheter aortic valve implantation
thumbnail
Congress Presentation
A comparison of self-expanding and balloon-expandable valves in pacemaker implantation rates in TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources